Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu injection for acute exacerbation of chronic heart failure due to coronary heart disease
ChiCTR-TRC-12002857Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Dec 2012
- Countries
- 1
01
Overview
Phase 4, randomised trial of shenfu injection in chronic heart failure (CHF) and coronary arteriosclerosis (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: NYHA functional class efficacy and TCM symptom score efficacy. Started Dec 2012; status: completed.
02
Drugs
shenfu injection
03
Conditions
chronic heart failure (CHF)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002857.